Adaptive Biotechnologies and Collaborators to Present Data from More Than 25 clonoSEQ® Abstracts at ASH 2019 Demonstrating Clinical Relevance of Standardized, Accurate MRD Testing for Blood Cancer Patients


You May Also Like

AlloSure Featured in Journal of the American Society of Nephrology

BRISBANE, Calif., March 09, 2017 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company ...

Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences

CAMBRIDGE, Mass., Feb. 01, 2016 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), a biotechnology ...